(TT) Trane Technologies - Overview
Sector: Industrials | Industry: Building Products & Equipment | Exchange: NYSE (USA) | Market Cap: 94.935m USD | Total Return: 30.2% in 12m
Avg Trading Vol: 563M USD
Peers RS (IBD): 80.4
EPS Trend: -3.4%
Qual. Beats: 0
Rev. Trend: 80.6%
Qual. Beats: 0
Trane Technologies plc designs, manufactures, sells, and services heating, ventilation, air conditioning (HVAC), and refrigeration solutions. The companys product portfolio includes air conditioners, chillers, heat pumps, and transport refrigeration systems, addressing diverse climate control needs.
The business model centers on providing comprehensive climate control solutions across various sectors, including commercial buildings and transport. This often involves long-term service contracts and aftermarket parts sales, generating recurring revenue in addition to equipment sales. The HVAC industry is characterized by cyclical demand influenced by construction trends and energy efficiency regulations.
Trane Technologies offers a wide array of products, from residential furnaces and humidifiers to industrial process refrigeration and data center HVAC systems. Their offerings also extend to specialized areas like medical-grade refrigeration and decarbonization programs, reflecting a focus on diverse market segments and sustainability initiatives. Companies in the building products sector often benefit from infrastructure development and energy efficiency mandates.
To gain further insights into Trane Technologies market position and financial health, consider exploring its detailed performance data.
- Commercial HVAC demand drives revenue growth
- Residential HVAC market fluctuations impact sales
- Transport refrigeration sales tied to global trade
- Energy efficiency regulations boost product adoption
- Raw material costs influence profit margins
| Net Income: 2.92b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA -0.50 > 1.0 |
| NWC/Revenue: 7.39% < 20% (prev 6.40%; Δ 1.00% < -1%) |
| CFO/TA 0.15 > 3% & CFO 3.22b > Net Income 2.92b |
| Net Debt (2.85b) to EBITDA (4.28b): 0.67 < 3 |
| Current Ratio: 1.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (223.6m) vs 12m ago -1.63% < -2% |
| Gross Margin: 36.16% > 18% (prev 0.36%; Δ 3.58k% > 0.5%) |
| Asset Turnover: 102.6% > 50% (prev 98.47%; Δ 4.12% > 0%) |
| Interest Coverage Ratio: 17.17 > 6 (EBITDA TTM 4.28b / Interest Expense TTM 227.5m) |
| A: 0.07 (Total Current Assets 7.86b - Total Current Liabilities 6.29b) / Total Assets 21.42b |
| B: 0.49 (Retained Earnings 10.42b / Total Assets 21.42b) |
| C: 0.19 (EBIT TTM 3.91b / Avg Total Assets 20.78b) |
| D: 0.80 (Book Value of Equity 10.23b / Total Liabilities 12.82b) |
| Altman-Z'' Score: 4.17 = AA |
| DSRI: 0.97 (Receivables 3.24b/3.09b, Revenue 21.32b/19.84b) |
| GMI: 0.99 (GM 36.16% / 35.69%) |
| AQI: 0.99 (AQ_t 0.53 / AQ_t-1 0.54) |
| SGI: 1.07 (Revenue 21.32b / 19.84b) |
| TATA: -0.01 (NI 2.92b - CFO 3.22b) / TA 21.42b) |
| Beneish M-Score: -3.03 (Cap -4..+1) = AA |
Over the past week, the price has changed by +4.11%, over one month by -3.98%, over three months by +9.50% and over the past year by +30.20%.
- StrongBuy: 7
- Buy: 2
- Hold: 15
- Sell: 0
- StrongSell: 2
| Wallstreet Target Price | 479.6 | 15.1% |
| Analysts Target Price | 479.6 | 15.1% |
P/E Forward = 29.0698
P/S = 4.4525
P/B = 11.0454
P/EG = 2.101
Revenue TTM = 21.32b USD
EBIT TTM = 3.91b USD
EBITDA TTM = 4.28b USD
Long Term Debt = 3.92b USD (from longTermDebt, last quarter)
Short Term Debt = 693.0m USD (from shortTermDebt, last quarter)
Debt = 4.62b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.85b USD (from netDebt column, last quarter)
Enterprise Value = 97.79b USD (94.94b + Debt 4.62b - CCE 1.76b)
Interest Coverage Ratio = 17.17 (Ebit TTM 3.91b / Interest Expense TTM 227.5m)
EV/FCF = 34.44x (Enterprise Value 97.79b / FCF TTM 2.84b)
FCF Yield = 2.90% (FCF TTM 2.84b / Enterprise Value 97.79b)
FCF Margin = 13.32% (FCF TTM 2.84b / Revenue TTM 21.32b)
Net Margin = 13.69% (Net Income TTM 2.92b / Revenue TTM 21.32b)
Gross Margin = 36.16% ((Revenue TTM 21.32b - Cost of Revenue TTM 13.61b) / Revenue TTM)
Gross Margin QoQ = 34.09% (prev 36.89%)
Tobins Q-Ratio = 4.57 (Enterprise Value 97.79b / Total Assets 21.42b)
Interest Expense / Debt = 1.20% (Interest Expense 55.6m / Debt 4.62b)
Taxrate = 16.57% (122.8m / 741.3m)
NOPAT = 3.26b (EBIT 3.91b * (1 - 16.57%))
Current Ratio = 1.25 (Total Current Assets 7.86b / Total Current Liabilities 6.29b)
Debt / Equity = 0.54 (Debt 4.62b / totalStockholderEquity, last quarter 8.60b)
Debt / EBITDA = 0.67 (Net Debt 2.85b / EBITDA 4.28b)
Debt / FCF = 1.00 (Net Debt 2.85b / FCF TTM 2.84b)
Total Stockholder Equity = 8.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.04% (Net Income 2.92b / Total Assets 21.42b)
RoE = 36.17% (Net Income TTM 2.92b / Total Stockholder Equity 8.07b)
RoCE = 32.58% (EBIT 3.91b / Capital Employed (Equity 8.07b + L.T.Debt 3.92b))
RoIC = 25.64% (NOPAT 3.26b / Invested Capital 12.71b)
WACC = 9.22% (E(94.94b)/V(99.55b) * Re(9.62%) + D(4.62b)/V(99.55b) * Rd(1.20%) * (1-Tc(0.17)))
Discount Rate = 9.62% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.38%
[DCF] Terminal Value 77.71% ; FCFF base≈2.81b ; Y1≈3.47b ; Y5≈5.92b
[DCF] Fair Price = 353.7 (EV 81.15b - Net Debt 2.85b = Equity 78.29b / Shares 221.3m; r=9.22% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -3.38 | EPS CAGR: -44.61% | SUE: -4.0 | # QB: 0
Revenue Correlation: 80.65 | Revenue CAGR: 12.07% | SUE: 0.25 | # QB: 0
EPS next Quarter (2026-06-30): EPS=4.30 | Chg7d=-0.001 | Chg30d=-0.002 | Revisions Net=-5 | Analysts=20
EPS current Year (2026-12-31): EPS=14.81 | Chg7d=-0.003 | Chg30d=-0.002 | Revisions Net=+1 | Growth EPS=+13.4% | Growth Revenue=+8.8%
EPS next Year (2027-12-31): EPS=16.82 | Chg7d=-0.003 | Chg30d=-0.003 | Revisions Net=+1 | Growth EPS=+13.6% | Growth Revenue=+8.0%
[Analyst] Revisions Ratio: -0.38 (4 Up / 9 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.6% (Discount Rate 9.6% - Earnings Yield 3.1%)
[Growth] Growth Spread = +0.8% (Analyst 7.3% - Implied 6.6%)